Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

Provide Feedback |

Submit a Case

Press Release/Announcement

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 6, 2007.

This announcement alerts health care providers to the potential for life-threatening errors involving two heparin products and provides recommendations to minimize mistakes.

Summary

Letter (PDF)

Related Resources

ISMP survey on tall man (mixed case) lettering to reduce drug name confusion.

November 16, 2022

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Annual Perspective

Annual Perspective: Topics in Medication Safety

March 31, 2022

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

WebM&M Cases

The Impact of Communication on Medication Errors

March 15, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

WebM&M Cases

Multiple Levels Involved in Prescribing the Wrong Medication

September 30, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Standardising the classification of harm associated with medication errors: the Harm Associated with Medication Error Classification (HAMEC).

May 15, 2019

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.

November 2, 2016

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

August 5, 2015

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

Indication alerts intercept drug name confusion errors during computerized entry of medication orders.

September 3, 2014

Look alike/sound alike drugs: a literature review on causes and solutions.

June 11, 2014

Potential inaccuracy of electronically transmitted medication history information used for medication reconciliation.

February 26, 2014

Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements.

September 4, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

ISMP medication error report analysis.

April 21, 2010

ISMP medication error report analysis.

March 10, 2010

See More About

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

PSNet Log in

Submit Your Case

Continue as a Guest

Continue Logged In

Submit Your Case

Continue as a Guest

Already have a PSNet

Account?

New Users